Lord, Abbett & Co. LLC Bristol Myers Squibb CO Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $67.6 Million - $78.8 Million	-1,260,707 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $4.38 Million - $5.13 Million	-73,954 Reduced 5.54%	1,260,707 $74.6 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $82.5 Million - $89.8 Million	-1,332,022 Reduced 49.95%	1,334,661 $89.2 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $5.16 Million - $5.81 Million	87,017 Added 3.37%	2,666,683 $168 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $4.01 Million - $4.54 Million	69,438 Added 2.77%	2,579,666 $160 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $2.78 Million - $3.08 Million	-48,440 Reduced 1.89%	2,510,228 $151 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $90.4 Million - $106 Million	1,649,915 Added 181.56%	2,558,668 $150 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $42.2 Million - $61.3 Million	908,753 New	908,753 $50.7 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $27.2 Million - $35.5 Million	-552,800 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $393,484 - $466,532	-9,200 Reduced 1.64%	552,800 $28 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $6.99 Million - $7.73 Million	-156,721 Reduced 21.81%	562,000 $25.5 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $5.01 Million - $5.98 Million	111,101 Added 18.28%	718,721 $34.3 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.13 Million - $1.46 Million	-23,148 Reduced 3.67%	607,620 $31.6 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $518,786 - $585,150	-9,400 Reduced 1.47%	630,768 $39.2 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $4.33 Million - $5.4 Million	85,688 Added 15.45%	640,168 $35.4 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $671,882 - $773,472	-11,213 Reduced 1.98%	554,480 $35.1 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $1.68 Million - $1.83 Million	-27,989 Reduced 4.71%	565,693 $34.7 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $9,112 - $10,517	-165 Reduced 0.03%	593,682 $37.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	593,847	593,847 $33.1 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account